The Latest News
Two Members of the Tullis Health Investors Advisory Board, Dr. David Leffell and Dr. Barbara Bierer, Become Venture Partners
Tullis Health Investors is pleased to announce that Dr. David Leffell, Chair of the Tullis Health Investors Advisory Board, and Dr. Barbara Bierer, a long-time member of the Board, have each taken additional responsibilities as Venture Partners of Tullis.
“Barbara and David are major contributors on our Advisory Board. We welcome them to the additional role of Venture Partner, in which context they will be more directly involved in the development, review, diligence and management of new investments by our funds and will participate increasingly in our internal investment process,” said Jim Tullis, Founder of Tullis Health Investors.
Dr. Leffell is the David Paige Smith Professor of Dermatology and Surgery at the Yale School of Medicine in New Haven, Connecticut. He is Chief of the Section of Dermatologic Surgery and Cutaneous Oncology in the School of Medicine and attending physician at Yale New Haven Hospital. For 15 years, he was CEO of the Yale Medical Group and is widely credited with transforming the faculty practice into a competitive, nationally recognized, physician practice group. Until 2013, he also served as Deputy Dean for Clinical Affairs of the Yale School of Medicine. David was also the lead executive in developing the electronic medical record and strategies for clinical practice growth, affiliated practice development, and clinical trials. His research interests include the genetics of skin cancer and melanoma. David graduated with honors from Yale College and attended McGill University Faculty of Medicine in his hometown of Montreal, Canada.
Dr. Barbara Bierer is Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital in Boston, Massachusetts, and a hematologist/oncologist. She joined our Advisory Board in December, 2009. She is the faculty co-chair of the Multi-Regional Clinical Trials Center at Harvard University (Harvard MRCT), a study center whose purpose is to improve the ethical, logistical and regulatory aspects of international clinical trials, with a special focus on the emerging economies, and The Director of the Regulatory Foundations, Ethics and Law Program of The Harvard Clinical and Translational Sciences Center. She founded the BWH Innovation Hub (iHub), a focus for entrepreneurship and innovation. Previously, she served as senior vice president, research at the Brigham and Women’s Hospital for 11 years, and as chair of the Secretary’s Advisory Committee on Human Research Protections, HHS. Barbara graduated with honors from Yale College and attended Harvard Medical School.